Does LUSPATERCEPT-AAMT Cause Hospitalisation? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Hospitalisation have been filed in association with LUSPATERCEPT-AAMT. This represents 2.2% of all adverse event reports for LUSPATERCEPT-AAMT.
37
Reports of Hospitalisation with LUSPATERCEPT-AAMT
2.2%
of all LUSPATERCEPT-AAMT reports
1
Deaths
36
Hospitalizations
How Dangerous Is Hospitalisation From LUSPATERCEPT-AAMT?
Of the 37 reports, 1 (2.7%) resulted in death, 36 (97.3%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUSPATERCEPT-AAMT. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does LUSPATERCEPT-AAMT Cause?
Death (162)
Haemoglobin decreased (98)
Fatigue (86)
Off label use (85)
Weight decreased (76)
Dizziness (64)
Product storage error (64)
Drug ineffective (58)
Dyspnoea (52)
Fall (51)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which LUSPATERCEPT-AAMT Alternatives Have Lower Hospitalisation Risk?
LUSPATERCEPT-AAMT vs LUTEIN
LUSPATERCEPT-AAMT vs LUTETIUM LU-177
LUSPATERCEPT-AAMT vs LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
LUSPATERCEPT-AAMT vs LUTETIUM OXODOTREOTIDE LU-177
LUSPATERCEPT-AAMT vs LUTROPIN ALFA